Y Intercept (Hong Kong) LTD Staar Surgical CO Transaction History

Y Intercept (Hong Kong) LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$46.82 - $76.2 $154,880 - $252,069	3,308 Added 24.96%	16,560 $803,000
Q3 2022 Feb 14, 2023	BUY	$70.55 - $111.58 $934,928 - $1.48 Million	13,252 New	13,252 $934,000
Q1 2022 May 16, 2022	SELL	$57.98 - $93.5 $245,255 - $395,505	-4,230 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$88.02 - $127.79 $78,073 - $113,349	887 Added 26.53%	4,230 $386,000
Q3 2021 Nov 15, 2021	BUY	$122.75 - $162.68 $410,353 - $543,839	3,343 New	3,343 $430,000

255

47.8M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.28B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.